DK119880B - Fremgangsmåde til fremstilling af beroligelsesmidler for centralnervesystemet i form af derivater af 4-oxo-1,3,8-triazaspiro-(4,5)-decan. - Google Patents
Fremgangsmåde til fremstilling af beroligelsesmidler for centralnervesystemet i form af derivater af 4-oxo-1,3,8-triazaspiro-(4,5)-decan.Info
- Publication number
- DK119880B DK119880B DK297763AA DK297763A DK119880B DK 119880 B DK119880 B DK 119880B DK 297763A A DK297763A A DK 297763AA DK 297763 A DK297763 A DK 297763A DK 119880 B DK119880 B DK 119880B
- Authority
- DK
- Denmark
- Prior art keywords
- triazaspiro
- sedatives
- decane
- oxo
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Wire Processing (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20462362A | 1962-06-22 | 1962-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK119880B true DK119880B (da) | 1971-03-08 |
Family
ID=22758700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK297763AA DK119880B (da) | 1962-06-22 | 1963-06-22 | Fremgangsmåde til fremstilling af beroligelsesmidler for centralnervesystemet i form af derivater af 4-oxo-1,3,8-triazaspiro-(4,5)-decan. |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE633914A (de) |
| CH (1) | CH462835A (de) |
| DE (1) | DE1470125C3 (de) |
| DK (1) | DK119880B (de) |
| FI (1) | FI46967C (de) |
| FR (6) | FR1573808A (de) |
| GB (1) | GB1043141A (de) |
| NO (1) | NO117368B (de) |
| SE (1) | SE311019B (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK154950B (da) * | 1975-07-21 | 1989-01-09 | Janssen Pharmaceutica Nv | Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4080328A (en) * | 1971-07-13 | 1978-03-21 | Sumitomo Chemical Company, Limited | N-substituted heterocyclic derivatives and preparation thereof |
| BE792187A (fr) * | 1971-12-03 | 1973-03-30 | Sumitomo Chemical Co | Nouveaux derives d'alkylamines |
| US4066772A (en) * | 1975-07-21 | 1978-01-03 | Janssen Pharmaceutica N.V. | 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds |
| DK139684A (da) * | 1983-04-11 | 1984-10-12 | Janssen Pharmaceutica Nv | N-aryl-alpha-amino-carboxamider |
| US5703088A (en) * | 1989-08-21 | 1997-12-30 | Beth Israel Deaconess Medical Center, Inc. | Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| US5244902A (en) * | 1989-08-21 | 1993-09-14 | Beth Israel Hospital Association | Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| US5574041A (en) * | 1990-03-16 | 1996-11-12 | Beth Israel Hospital Association | Use of spiperone derivatives as immunosuppressant agents |
| US5693645A (en) * | 1992-12-23 | 1997-12-02 | Beth Israel Deaconess Medical Center, Inc. | Use of spiperone or spiperone derivatives as immunosuppressant agents |
| DE19610397A1 (de) * | 1996-03-16 | 1997-09-18 | Krewel Meuselbach Gmbh | Gewinnung von Fluspirilen-Suspensionen |
| WO1999059997A1 (en) * | 1998-05-18 | 1999-11-25 | Novo Nordisk A/S | Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
| US6277991B1 (en) | 1998-05-18 | 2001-08-21 | Novo Nordisk A/S | 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
| US6262066B1 (en) * | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| EP0997464B1 (de) * | 1998-10-23 | 2005-02-16 | Pfizer Inc. | 1,3,8-Triazaspiro[4,5] decanon Verbindungen als orl1-receptor Agonisten |
| US7459461B2 (en) | 2001-10-19 | 2008-12-02 | Ortho-Mcneil Pharmaceutical, Inc. | Phosphonic acid compounds as inhibitors of serine proteases |
| DE102005038141A1 (de) * | 2005-08-12 | 2007-02-15 | Grünenthal GmbH | Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate |
| MX2012014470A (es) * | 2010-06-18 | 2013-06-13 | Altos Therapeutics Llc | Antagonistas d2, metodos de sintesis y metodos de uso. |
| IT201800007580A1 (it) * | 2018-07-27 | 2020-01-27 | Maria Cecilia Hospital Spa | Composti 1,3,8-triazaspiro e loro uso come medicamenti |
-
0
- BE BE633914D patent/BE633914A/xx unknown
-
1963
- 1963-06-19 SE SE6834/63A patent/SE311019B/xx unknown
- 1963-06-21 NO NO149114A patent/NO117368B/no unknown
- 1963-06-21 CH CH776363A patent/CH462835A/de unknown
- 1963-06-21 GB GB24824/63A patent/GB1043141A/en not_active Expired
- 1963-06-21 DE DE1470125A patent/DE1470125C3/de not_active Expired
- 1963-06-21 FI FI631267A patent/FI46967C/fi active
- 1963-06-22 FR FR1573808D patent/FR1573808A/fr not_active Expired
- 1963-06-22 DK DK297763AA patent/DK119880B/da unknown
- 1963-09-20 FR FR948244A patent/FR3059M/fr active Active
- 1963-09-20 FR FR948240A patent/FR3043M/fr active Active
- 1963-09-20 FR FR948243A patent/FR2988M/fr active Active
- 1963-09-20 FR FR948242A patent/FR2987M/fr active Active
- 1963-09-20 FR FR948241A patent/FR2986M/fr active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK154950B (da) * | 1975-07-21 | 1989-01-09 | Janssen Pharmaceutica Nv | Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1470125C3 (de) | 1980-07-10 |
| FI46967C (fi) | 1973-08-10 |
| FR2986M (fr) | 1964-12-07 |
| FR1573808A (de) | 1969-07-11 |
| FR2988M (fr) | 1964-12-07 |
| FR3059M (fr) | 1965-01-11 |
| CH462835A (de) | 1968-09-30 |
| FR3043M (fr) | 1965-01-04 |
| FI46967B (de) | 1973-05-02 |
| NO117368B (de) | 1969-08-04 |
| FR2987M (fr) | 1964-12-07 |
| GB1043141A (en) | 1966-09-21 |
| SE311019B (de) | 1969-05-27 |
| BE633914A (de) | |
| DE1470125B2 (de) | 1979-10-31 |
| DE1470125A1 (de) | 1969-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK119880B (da) | Fremgangsmåde til fremstilling af beroligelsesmidler for centralnervesystemet i form af derivater af 4-oxo-1,3,8-triazaspiro-(4,5)-decan. | |
| DK107749C (da) | Fremgangsmåde til fremstilling af 5,6,7,7a,8,9-hexahydro-12-methyl-4aH-8,9c-iminoethanphenanthro-[4,5-b,c,d]-furanderivater. | |
| DK114058B (da) | Fremgangsmåde til fremstilling af 2,4-disulfamyl-N-(3-hydroxy-2-propenyliden)-anilinderivater. | |
| DK104363C (da) | Fremgangsmåde til fremstilling af symmetriske 4-halogen-4',4''-diarylamino-triphenylmethanfarvestoffer. | |
| DK108971C (da) | Fremgangsmåde til fremstilling af 6,17α -dimethylprogesteronderivater. | |
| DK105471C (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepin-3H-forbindelser. | |
| DK119702B (da) | Fremgangsmåde til fremstilling af 2,6-dichlorbenzonitril. | |
| FI46385C (fi) | Menetelmä terapeuttisesti arvokkaiden 1,3-dihydro-3-hydroksi-2H-1,4-be ntsodiatsepiini-2-onijohdannaisten valmistamiseksi. | |
| DK122080B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater. | |
| DK106554C (da) | Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-2(1H)-thioner. | |
| DK103025C (da) | Fremgangsmåde til fremstilling af 1,4-dioxanderivater. | |
| DK103081C (da) | Fremgangsmåde til fremstilling af 2,6-diketo-8-thiapuriner. | |
| DK115852B (da) | Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxymethyl-7,8-dihydropteridin. | |
| DK111175B (da) | Fremgangsmåde til fremstilling af 4',19-diacylcymaroler. | |
| DK108682C (da) | Fremgangsmåde til fremstilling af substituerede 9,10-dichlor-triphendioxazinfarvestoffer. | |
| DK116280B (da) | Fremgangsmåde til fremstilling af 4,5-dehydro-3-keto-19-nor-steroider. | |
| DK119209C (da) | Fremgangsmåde til fremstilling af i 7-stillingen substituerede 10-aminoalkylerede 10,11-dihydro-11-oxo-5H-dibenzo[b,e]-1,4-diazepiner. | |
| DK115333B (da) | Fremgangsmåde til fremstilling af 3,5-dioxopyrazolidinderivater. | |
| DK103513C (da) | Fremgangsmåde til fremstilling af monomethonium- eller bis-methoniumforbindelser af 3-azabicyclo-(3,2,2)-nonanderivater. | |
| DK118025B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater. | |
| DK122524B (da) | Fremgangsmåde til fremstilling af 3,8-diazabicyklo-(3,2,1)-oktaner. | |
| FI45046C (fi) | Menetelmä rauhoittavina aineina vaikuttavien fentiatsiinien 3,8-diatsa bisyklo-oktaani-johdannaisten valmistamiseksi. | |
| DK111486B (da) | Fremgangsmåde til fremstilling af 3-oxo-4-androsten-16α,2'-spiro-tetrahydrofuran-5'-on. | |
| DK104680C (da) | Fremgangsmåde til fremstilling af derivater af 6-methyl-8-aminomethyl-ergolin I. | |
| DK99013C (da) | Fremgangsmåde til fremstilling af 6,16-dimethyl-1,4,15-pregnatrienderivater. |